Leach, Joshua D. G.
Vlahov, Nikola
Tsantoulis, Petros http://orcid.org/0000-0003-3613-6682
Ridgway, Rachel A. http://orcid.org/0000-0003-0198-8244
Flanagan, Dustin J.
Gilroy, Kathryn
Sphyris, Nathalie http://orcid.org/0000-0003-1860-1958
Vázquez, Ester G.
Vincent, David F.
Faller, William J. http://orcid.org/0000-0002-0738-2254
Hodder, Michael C.
Raven, Alexander
Fey, Sigrid
Najumudeen, Arafath K. http://orcid.org/0000-0002-3764-5721
Strathdee, Douglas http://orcid.org/0000-0003-2959-4327
Nixon, Colin http://orcid.org/0000-0002-8085-2160
Hughes, Mark
Clark, William
Shaw, Robin
Maughan, Tim
Salto-Tellez, Manuel
Quirke, Philip
Koelzer, Viktor
Dunne, Philip
Beggs, Andrew
Campbell, Peter
Buffa, Francesca
Holmes, Chris
Kaplan, Rick
Brown, Louise
Lawler, Mark
Hordern, Joshua
Tomlinson, Ian
Leedham, Simon
Morton, Dion
van Hooff, Sander R.
Huels, David J.
Medema, Jan Paul
Barry, Simon T.
Frame, Margaret C. http://orcid.org/0000-0001-5882-1942
Unciti-Broceta, Asier http://orcid.org/0000-0003-1029-2855
Leedham, Simon J.
Inman, Gareth J. http://orcid.org/0000-0002-6264-4253
Jackstadt, Rene
Thompson, Barry J. http://orcid.org/0000-0002-0103-040X
Campbell, Andrew D. http://orcid.org/0000-0003-3930-1276
Tejpar, Sabine
Sansom, Owen J. http://orcid.org/0000-0001-9540-3010
,
Funding for this research was provided by:
Cancer Research UK (A29055, A21139, A26835)
Article History
Received: 13 August 2020
Accepted: 11 May 2021
First Online: 8 June 2021
Competing interests
: S.T.B. is an employee of AstraZeneca. O.J.S. receives funding from AstraZeneca and Novartis. All other authors declare no conflicts of interest.